PVLA director buys 445 Palvella shares at $112.30
PALVELLA THERAPEUTICS, INC. director George M. Jenkins made an open-market purchase of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PALVELLA THERAPEUTICS, INC. director George M. Jenkins made an open-market purchase of common stock. On March 30, 2026, he bought 445 shares of Palvella Therapeutics common stock at $112.30 per share. Following this trade, he directly holds 187,616 shares and has an additional 13,516 shares reported as indirectly held through the Eagles Mere Air Museum Foundation.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 445 | $112.30 | $50K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Eagles Mere Air Museum Foundation.
Key Figures
Key Terms
open-market purchase financial
indirect ownership financial
Common Stock financial
Eagles Mere Air Museum Foundation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Palvella Therapeutics (PVLA) director George M. Jenkins do in this Form 4?
What are George M. Jenkins’ total direct Palvella Therapeutics (PVLA) holdings after this trade?
Does George M. Jenkins have any indirect ownership in Palvella Therapeutics (PVLA)?
What does the Eagles Mere Air Museum Foundation reference mean in the PVLA Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.